Digestive System Neoplasms
Research from D. Schallier and co-authors provides new data about digestive system neoplasms
Published in Women's Health Weekly, March 4th, 2010
"The tyrosine kinase inhibitors (TKI) sunitinib and imatinib were shown to induce macrocytosis in patients with renal cell cancer (RCC) and gastrointestinal stromal tumors (GIST), presumably through inhibition of the c-KIT dependent signaling pathway of erythroid progenitor cells of the bone marrow. Hematology charts of patients with RCC, breast cancer (BC), GIST, non-small cell lung cancer (NSCLC) and hepatocellular cancer (HCC), receiving single-agent sunitinib, imatinib, sorafenib, erlotinib and BI 2992 (Tovok) at the recommended dose for at least 3 months were reviewed retrospectively for the occurrence Of macrocytosis," scientists in Brussels, Belgium report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Baylor College of Medicine
Master gene SRC-3 enables breast cancer growth, invasion - Journal of the National Cancer Institute
News brief: Benefit of HPV vaccination, frequent screening for women over 41 is likely to be low - American Medical Systems
American Medical Systems Announces Sale of Her Option(R) Global Endometrial Ablation Product Line - Angiogenesis
Research from Nanjing Medical University in angiogenesis provides new insights - Apoptosis
Report summarizes apoptosis study findings from Q.Y. Zeng and co-researchers - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Rated Among Top 15 Companies on the Biotechnology Patent Scorecard(TM) as published in the Wall Street Journal - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
